Cargando…

Economic burden of cardiovascular diseases before and after Iran’s health transformation plan: evidence from a referral hospital of Iran

BACKGROUND: Different countries have set different policies to control and decrease the costs of cardiovascular diseases (CVDs). Iran was aiming to reduce the economic burden of different disease by a recent reform from named as health transformation plan (HTP). This study aimed to examine the econo...

Descripción completa

Detalles Bibliográficos
Autores principales: Alipour, Vahid, Zandian, Hamed, Yazdi-Feyzabadi, Vahid, Avesta, Leili, Moghadam, Telma Zahirian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778796/
https://www.ncbi.nlm.nih.gov/pubmed/33390167
http://dx.doi.org/10.1186/s12962-020-00250-8
_version_ 1783631197208838144
author Alipour, Vahid
Zandian, Hamed
Yazdi-Feyzabadi, Vahid
Avesta, Leili
Moghadam, Telma Zahirian
author_facet Alipour, Vahid
Zandian, Hamed
Yazdi-Feyzabadi, Vahid
Avesta, Leili
Moghadam, Telma Zahirian
author_sort Alipour, Vahid
collection PubMed
description BACKGROUND: Different countries have set different policies to control and decrease the costs of cardiovascular diseases (CVDs). Iran was aiming to reduce the economic burden of different disease by a recent reform from named as health transformation plan (HTP). This study aimed to examine the economic burden of CVDs before and after of HTP. METHODS: This cross-sectional study was conducted on 600 patients with CVDs, who were randomly selected from a specialized cardiovascular hospital in the north-west of Iran. Direct and indirect costs of CVDs were calculated using the cost of illness and human capital approaches. Data were collected using a researcher-made checklist obtained from several sources including structured interviews, the Statistical Center of Iran, Iran’s Ministry of Cooperatives, Labor, and Social Welfare, the central bank of Iran, and the data of global burden of disease obtained from the Institute for Health Metrics and Evaluation to estimate direct and mortality costs. All costs were calculated in Iranian Rials (IRR). RESULTS: Total costs of CVDs were about 5571 and 6700 billion IRR before and after the HTP, respectively. More than 62% of the total costs of CVDs accounted for premature death before (64.89%) and after (62.01%) the HTP. The total hospitalization costs of CVDs was significantly increased after the HTP (p = 0.038). In both times, surgical services and visiting had the highest and lowest share of hospitalization costs, respectively. The OOP expenditure decreased significantly and reached from 54.2 to 36.7%. All hospitalization costs, except patients’ OOP expenditure, were significantly increased after the HTP about 1.3 times. Direct non-medical costs reached from 2.4 to 3.3 billion before and after the HTP, respectively. CONCLUSION: Economic burden of CVDs increased in the north-west of Iran after the HTP due to the increase of all direct and indirect costs, except the OOP expenditure. Non-allocation of defined resources, which coincided with the international and national political and economic challenges in Iran, led to unsustainable resources of the HTP. So, no results of this study can be attributed solely to the HTP. Therefore, more detailed studies should be carried out on the reasons for the significant increase in CVDs costs in the region.
format Online
Article
Text
id pubmed-7778796
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-77787962021-01-04 Economic burden of cardiovascular diseases before and after Iran’s health transformation plan: evidence from a referral hospital of Iran Alipour, Vahid Zandian, Hamed Yazdi-Feyzabadi, Vahid Avesta, Leili Moghadam, Telma Zahirian Cost Eff Resour Alloc Research BACKGROUND: Different countries have set different policies to control and decrease the costs of cardiovascular diseases (CVDs). Iran was aiming to reduce the economic burden of different disease by a recent reform from named as health transformation plan (HTP). This study aimed to examine the economic burden of CVDs before and after of HTP. METHODS: This cross-sectional study was conducted on 600 patients with CVDs, who were randomly selected from a specialized cardiovascular hospital in the north-west of Iran. Direct and indirect costs of CVDs were calculated using the cost of illness and human capital approaches. Data were collected using a researcher-made checklist obtained from several sources including structured interviews, the Statistical Center of Iran, Iran’s Ministry of Cooperatives, Labor, and Social Welfare, the central bank of Iran, and the data of global burden of disease obtained from the Institute for Health Metrics and Evaluation to estimate direct and mortality costs. All costs were calculated in Iranian Rials (IRR). RESULTS: Total costs of CVDs were about 5571 and 6700 billion IRR before and after the HTP, respectively. More than 62% of the total costs of CVDs accounted for premature death before (64.89%) and after (62.01%) the HTP. The total hospitalization costs of CVDs was significantly increased after the HTP (p = 0.038). In both times, surgical services and visiting had the highest and lowest share of hospitalization costs, respectively. The OOP expenditure decreased significantly and reached from 54.2 to 36.7%. All hospitalization costs, except patients’ OOP expenditure, were significantly increased after the HTP about 1.3 times. Direct non-medical costs reached from 2.4 to 3.3 billion before and after the HTP, respectively. CONCLUSION: Economic burden of CVDs increased in the north-west of Iran after the HTP due to the increase of all direct and indirect costs, except the OOP expenditure. Non-allocation of defined resources, which coincided with the international and national political and economic challenges in Iran, led to unsustainable resources of the HTP. So, no results of this study can be attributed solely to the HTP. Therefore, more detailed studies should be carried out on the reasons for the significant increase in CVDs costs in the region. BioMed Central 2021-01-03 /pmc/articles/PMC7778796/ /pubmed/33390167 http://dx.doi.org/10.1186/s12962-020-00250-8 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Alipour, Vahid
Zandian, Hamed
Yazdi-Feyzabadi, Vahid
Avesta, Leili
Moghadam, Telma Zahirian
Economic burden of cardiovascular diseases before and after Iran’s health transformation plan: evidence from a referral hospital of Iran
title Economic burden of cardiovascular diseases before and after Iran’s health transformation plan: evidence from a referral hospital of Iran
title_full Economic burden of cardiovascular diseases before and after Iran’s health transformation plan: evidence from a referral hospital of Iran
title_fullStr Economic burden of cardiovascular diseases before and after Iran’s health transformation plan: evidence from a referral hospital of Iran
title_full_unstemmed Economic burden of cardiovascular diseases before and after Iran’s health transformation plan: evidence from a referral hospital of Iran
title_short Economic burden of cardiovascular diseases before and after Iran’s health transformation plan: evidence from a referral hospital of Iran
title_sort economic burden of cardiovascular diseases before and after iran’s health transformation plan: evidence from a referral hospital of iran
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778796/
https://www.ncbi.nlm.nih.gov/pubmed/33390167
http://dx.doi.org/10.1186/s12962-020-00250-8
work_keys_str_mv AT alipourvahid economicburdenofcardiovasculardiseasesbeforeandafteriranshealthtransformationplanevidencefromareferralhospitalofiran
AT zandianhamed economicburdenofcardiovasculardiseasesbeforeandafteriranshealthtransformationplanevidencefromareferralhospitalofiran
AT yazdifeyzabadivahid economicburdenofcardiovasculardiseasesbeforeandafteriranshealthtransformationplanevidencefromareferralhospitalofiran
AT avestaleili economicburdenofcardiovasculardiseasesbeforeandafteriranshealthtransformationplanevidencefromareferralhospitalofiran
AT moghadamtelmazahirian economicburdenofcardiovasculardiseasesbeforeandafteriranshealthtransformationplanevidencefromareferralhospitalofiran